Tequin Articles
Japan stock market week to Oct 13, 2008
20 October 2008
FDA petitioned for warnings on fluoroquinolones
4 September 2006
Japan stock market week to May 1, 2006
8 May 2006
Public Citizen calls on FDA to ban Tequin
8 May 2006
Tokyo pharma stocks - week to November 8
15 November 2004
Tokyo pharma stocks - week July 19
26 July 2004
Tokyo pharma stocks - week to May 17
24 May 2004
Lupin launches oral generic cefixime in USA
19 April 2004
Tokyo pharma stocks - week to March 29
5 April 2004
Tokyo pharma stocks - week to Mar 1
8 March 2004
Dainippon revises down 2007 forecasts
1 March 2004
Tokyo pharma stocks - week to Feb 16
23 February 2004
Indian firms urge govt over life-saving drugs
5 January 2004
Kyorin on target in fiscal first-half
24 November 2003
Tokyo pharma stocks - week to Nov 10
17 November 2003
Stock Commentary - Tokyo
17 November 2003
Tokyo pharma stocks - week to July 14
21 July 2003
JB to enter new market and roll out products
21 July 2003
Tokyo pharma stocks - week to June 9
16 June 2003
Tokyo stocks to April 28
5 May 2003
Allergan's Zymar cleared in USA
7 April 2003
Tokyo pharma stocks - week to August 5
12 August 2002
Stock Commentary - Tokyo
12 August 2002
Tokyo pharma stocks - week to May 27
3 June 2002
Tokyo pharma stocks - week to April 8
15 April 2002
Tokyo pharma stocks - week to February 4
11 February 2002
Gruenenthal gets OK for gatifloxacin in Germany
6 December 2001
Dr Reddy's launches Gaity
22 November 2001
Tokyo pharma stocks - week to November 19
21 November 2001
Japan pharma stocks, week to Sept 3rd
5 September 2001
Stock Commentary - Tokyo
31 May 2001
Tokyo pharma stock market week to May 14
15 May 2001
US HMOs reveal their most-accepted drugs
5 April 2001
Kyorin setting up unit in the USA
2 February 2001
Bristol-Myers Squibb's "solid year" sees net earnings rise 13%
25 January 2001
Stock Commentary - Tokyo
4 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Stock Commentary - Tokyo
23 November 2000
B-MS net earnings increase 13%
23 October 2000
B-MS focuses on intense growth and reveals product pipeline
2 October 2000
Allergan licenses Kyorin's gatifloxacin
29 August 2000
Stock Commentary Tokyo
3 August 2000
Pfizer leads 1st-qtr US physician detailing
11 July 2000
Stock Commentary Tokyo
22 June 2000
Daiichi's advantage in antibiotic class
20 June 2000
Stock Commentary Tokyo
13 April 2000
Busy year for NCEs as major new compound classes launched
6 January 2000
First approval for B-MS' Tequin heats up antibiotic sector - update
30 December 1999
First approval for B-MS' Tequin heats up antibiotic sector
24 December 1999
SmithKline Beecham files for US approval of new quinolone
16 December 1999
Daiichi Pharma sales growth slower; Harmokisan approval delayed
15 November 1999
Johnson & Johnson wins FDA panel backing for Levaquin in CAP
21 October 1999
B-MS Files Tequin NDA
14 January 1999
New Antibacterials Showcased At ICAAC
14 October 1998
Gatifloxacin License
17 February 1998
Bristol-Myers Squibb To Focus On New Products
9 December 1997
Will New Wave Of Antibiotics Fight Resistance?
23 October 1997
Showing 1-71 of 71 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
